Skip to main content

Table 3 Median survival of animals in the vaccination study in human FcεRIα transgenic mice

From: A novel IgE antibody targeting the prostate-specific antigen as a potential prostate cancer therapy

 

Median survival (days)

p-value (compared to buffer control)

p-value (compared to PSA)

p-value (compared to PSA + anti-PSA IgG1)

Buffer

14.5

   

PSA

15

0.777

  

PSA + anti-PSA IgG1

16

0.086

0.147

 

PSA + anti-PSA IgE

22

0.004

0.005

0.01

  1. Data shown are combined from two independent experiments (n = 4 for each) with a total of 8 animals per group.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us